| Schedule of Basic and Diluted Net Loss Attributable to Common Stockholders |
The following table sets forth the computation of basic and diluted net loss attributable to Class A and Class B common stockholders per share (in thousands except per share data):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | | Three Months Ended June 30, 2025 | | | Class A | | Class B | | Class A | | Class B | | Numerator | | | | | | | | | | | | | | | | | | | Net loss attributable to common stockholders – basic | | $ | (11,562) | | | $ | (1,712) | | | $ | (2,561) | | | $ | (387) | | | Potential dilutive effect of derivative instruments | | — | | | — | | | — | | | — | | | Net loss attributable to common stockholders – diluted | | $ | (11,562) | | | $ | (1,712) | | | $ | (2,561) | | | $ | (387) | | | Denominator | | | | | | | | | | Weighted average shares of common stock outstanding - basic | | 111,159 | | | 16,458 | | | 108,990 | | | 16,458 | | Potential dilutive effect of derivative instruments | | — | | | — | | | — | | | — | | | Weighted average shares of common stock outstanding - diluted | | 111,159 | | | 16,458 | | | 108,990 | | | 16,458 | | | Net loss attributable to common stockholders per share | | | | | | | | | | Basic | | $ | (0.10) | | | $ | (0.10) | | | $ | (0.02) | | | $ | (0.02) | | | Diluted | | $ | (0.10) | | | $ | (0.10) | | | $ | (0.02) | | | $ | (0.02) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 | | | Class A | | Class B | | Class A | | Class B | | Numerator | | | | | | | | | | Net loss attributable to common stockholders – basic | | $ | (20,863) | | | $ | (3,087) | | | $ | (5,063) | | | $ | (765) | | | Potential dilutive effect of derivative instruments | | — | | | — | | | — | | | — | | | Net loss attributable to common stockholders – diluted | | $ | (20,863) | | | $ | (3,087) | | | $ | (5,063) | | | $ | (765) | | | Denominator | | | | | | | | | | Weighted average shares of common stock outstanding - basic | | 111,180 | | | 16,458 | | | 108,893 | | | 16,458 | | Potential dilutive effect of derivative instruments | | — | | | — | | | — | | | — | | | Weighted average shares of common stock outstanding - diluted | | 111,180 | | | 16,458 | | | 108,893 | | | 16,458 | | | Net loss attributable to common stockholders per share | | | | | | | | | | Basic | | $ | (0.19) | | | $ | (0.19) | | | $ | (0.05) | | | $ | (0.05) | | | Diluted | | $ | (0.19) | | | $ | (0.19) | | | $ | (0.05) | | | $ | (0.05) | |
|
| Schedule of Excluded Securities from Computation of Diluted Net Loss Per Share |
The following equity awards outstanding at the end of each period presented have been excluded from the computation of diluted net loss per share of common stock for the periods presented due to their anti-dilutive effect: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Stock options | 4,458 | | | 4,711 | | | 4,458 | | | 4,711 | | | Restricted stock units | 8,244 | | | 13,422 | | | 8,244 | | | 13,422 | | Performance stock units | 2,250 | | | 2,704 | | | 2,250 | | | 2,704 | | | Public Warrants | — | | | 5,382 | | | — | | | 5,382 | | | Private Warrants | — | | | 3,822 | | | — | | | 3,822 | | | Earnout Shares | — | | | 15,000 | | | — | | | 15,000 | | | 14,952 | | | 45,041 | | | 14,952 | | | 45,041 | |
|